Imlimthan, S.; Moon, E.S.; Rathke, H.; Afshar-Oromieh, A.; Rösch, F.; Rominger, A.; Gourni, E.
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals 2021, 14, 1023.
https://doi.org/10.3390/ph14101023
AMA Style
Imlimthan S, Moon ES, Rathke H, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E.
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals. 2021; 14(10):1023.
https://doi.org/10.3390/ph14101023
Chicago/Turabian Style
Imlimthan, Surachet, Euy Sung Moon, Hendrik Rathke, Ali Afshar-Oromieh, Frank Rösch, Axel Rominger, and Eleni Gourni.
2021. "New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress" Pharmaceuticals 14, no. 10: 1023.
https://doi.org/10.3390/ph14101023
APA Style
Imlimthan, S., Moon, E. S., Rathke, H., Afshar-Oromieh, A., Rösch, F., Rominger, A., & Gourni, E.
(2021). New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals, 14(10), 1023.
https://doi.org/10.3390/ph14101023